Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aspasia, Provata"'
Autor:
Elias Kotteas, Aspasia Provata, Ifigenia Tzannou, Kostas N. Syrigos, Eleni M. Karapanagiotou, Epaminondas Kosmas, Kalliopi D. Dilana, Ioannis Tourkantonis, Adrianni Charpidou
Publikováno v:
Medical Oncology. 25:303-308
Our study involves a preliminary phase II trial, which evaluates the activity, feasibility and tolerability of a sequential combination of docetaxel and gemcitabine followed by docetaxel and carboplatin, as first-line treatment for inoperable NSCLC.
Autor:
Elias, Kotteas, Christina, Alamara, Maria, Kiagia, Kosmas, Pantazopoulos, Anastasios, Boufas, Aspasia, Provata, Adrianni, Charpidou, Konstantinos N, Syrigos
Publikováno v:
Anticancer research. 28(1B)
Zoledronic acid (Zometa, Novartis, Basel, Switzerland) is a new generation of bisphosphonates (BPs) with demonstrated clinical benefit in breast and prostate cancer patients with bone metastases. The safety and efficacy of intravenous zoledronic acid
Autor:
Eleni Karapanagiotou, Adrianni Charpidou, Ifigenia Tzannou, Kalliopi Dilana, Elias Kotteas, Ioannis Tourkantonis, Epaminondas Kosmas, Aspasia Provata, Kostas Syrigos
Publikováno v:
Medical Oncology; Sep2008, Vol. 25 Issue 3, p303-308, 6p